Aspiriant Holdings S3’s Merck MRK Stock Holding History

Aspiriant Holdings S3’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$1.27M	Sell	25,278 -932	-4%	-$47K	0.55%	55
2015 Q3	$1.24M	Buy	26,210 +1,482	+6%	+$78.7K	0.57%	50
2015 Q2	$1.34M	Buy	24,728 +1,944	+9%	+$109K	0.54%	60
2015 Q1	$1.25M	Buy	22,784 +19	+0.1%	+$1.08K	0.5%	59
2014 Q4	$1.23M	Buy	22,765 +928	+4%	+$51.7K	0.51%	58
2014 Q3	$1.24M	Buy	21,837 +335	+2%	+$18.8K	0.5%	58
2014 Q2	$1.19M	Buy	21,502 +1,520	+8%	+$82.9K	0.47%	60
2014 Q1	$1.08M	Buy	19,982 +178	+0.9%	+$9.22K	0.46%	61
2013 Q4	$946K	Sell	19,804 -744	-4%	-$34K	0.37%	69
2013 Q3	$933K	Buy	20,548 +1,647	+9%	+$75.2K	0.39%	64
2013 Q2	$838K	Buy	+18,901	New	+$844K	0.38%	68

Other funds holding MRK

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LTI

Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Aspiriant Holdings S3's MRK Position: Q4 2015 in Review

Aspiriant Holdings S3 reduced its Merck (MRK) stake by 3.6% in Q4 2015, selling an estimated $47K and leaving 25,278 shares worth $1.27M. The position accounts for 0.55% of the portfolio, ranked #55.

Aspiriant Holdings S3 first reported a position in MRK in Q2 2013 and has held it in 11 quarters since. The position peaked at $1.34M in Q2 2015. 1,754 funds tracked by Wall St. Rank hold MRK as of Q4 2015.

Aspiriant Holdings S3 held 25,278 shares of Merck worth $1.27M as of Q4 2015.
Aspiriant Holdings S3 sold 932 Merck shares in Q4 2015, an estimated $47K.
Merck made up 0.55% of Aspiriant Holdings S3's portfolio in Q4 2015, its #55 holding.
Aspiriant Holdings S3 first reported a position in Merck in Q2 2013 and has held it in 11 quarters since.
Aspiriant Holdings S3's Merck position peaked at $1.34M in Q2 2015.
1,754 funds tracked by Wall St. Rank held Merck as of Q4 2015.

Based on Aspiriant Holdings S3's 13F filing for Q4 2015, filed 13 Jan 2016.